3D Systems reported its Q3 2026 financial results: total revenue of $99.3 million, up 8.8% year-on-year (products $58.2 million plus services $41.1 million); gross margin rose from 32.3% to 35.0%, and adjusted EBITDA turned positive at $3.1 million (versus -$10 million in the prior-year period); GAAP net loss was $33.5 million (versus $18.1 million in the prior-year period), mainly due to litigation costs, asset impairments, and changes in foreign exchange and tax items. By market, healthcare revenue rose 14% year-on-year to $49 million, while aerospace and defense revenue (excluding the Air Force development program) grew 50% year-on-year. Management emphasized that revenue and margins improved simultaneously across its four key markets: medical devices, dental, aerospace and defense, and data centers. Founded by Chuck Hull in 1986 (the inventor of stereolithography SLA technology), 3D Systems is headquartered in South Carolina, USA, and listed on the New York Stock Exchange (NYSE: DDD). Its business covers metal and polymer printing equipment, materials, and healthcare solutions, making it a long-established player in the global additive manufacturing industry. A recovery in equipment installations, combined with surging demand from healthcare and aerospace and defense, directly benefits upstream metal powder and consumables shipments. The simultaneous improvement in gross margin and EBITDA at a leading industry player provides financial-report-level validation of the strong momentum across the powder and equipment supply chain. Increased equipment purchasing by healthcare, dental, and aerospace and defense customers will drive repeat demand for corresponding powders and consumables. Buyers may wish to monitor the supply and pricing cycles of upstream materials.